Embolization of the Middle Meningeal Artery with ONYX In the Treatment of Subacute and Chronic Subdural Hematoma

Clinical Trial Information

Trial Contact: Carlo, Charlene S, Monserrate, Francheska, Melendez, Thomas L

IRB No: WCG 20193350

Principal Investigator: Cress, Marshall C., MD

Phase: N/A

Age Group: ADULTOLDER_ADULT

ClinicalTrials.gov ID: NCT04402632

Objective

The objective of this study is to evaluate the safety and effectiveness of Onyx™ LES embolization of the MMA as an adjunct to conventional treatment (surgery or observation) for symptomatic subacute or chronic subdural hematoma.

Share:

Related Clinical Trials

RETROSPECTIVE REVIEW OF PLAVIX RESISTANCE IN CENTRAL FLORIDA PATIENTS UNDERWENT TRANSCAROTID ARTERY REVASCULARIZATION (TCAR)
Are Premature Infants with Bronchopulmonary Dysplasia Requiring Tracheostomy and Ventilation at Increased Risk of Atypical Craniosynostosis?
Randomized Trial Comparing Novel Fluoroscopy System with Conventional Fluoroscopy System in Fluoroscopy-Guided Endoscopic Procedures
A Phase I/II Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6621, a T Cell-Engaging Antibody that Targets STEAP2, CD3, and CD8 in Adult Participants with Metastatic Prostate Cancer (ACTIVATED-4-PC)